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Abstract 
AIM: To evaluate the efficacy of oral isotretinoin used alone and in combination with desloratadine in the 
treatment of moderate acne vulgaris. 
METHODS: A comparative clinical trial was undertaken to evaluate the efficacy of oral isotretinoin alone and in 
combination with desloratadine in the treatment of 62 moderate acne vulgaris patients. Patients were randomised 
into two groups with 31 patients in each group. Each studied group's patient took 20 mg isotretinoin and 5 mg 
desloratadine per day. In the control group, patients took only 20 mg isotretinoin per day. The treatment time was 
16 weeks. The evaluation and follow-up were done at week 2, 4, 8, 12 and 16 of the treatment.  
RESULTS: The studied group had a better curative rate than the control group (45.2% versus 22.6%). The 
average number of inflammatory lesions in the studied group was significantly lower than the control group (0.19 
versus 0.94). The mean GAGS score of the studied group was significantly lower than the control group (3.71 
versus 6.52). Acne outbreaks rate of the studied group was lower than the control group (in week 2: 22.6% versus 
45.2% and in week 4: 16.1% versus 38.7%, respectively). The rate of itchy was lower in the studied group.  
CONCLUSION: In the treatment of moderate acne vulgaris, oral isotretinoin in combination with desloratadine is 
more effective and has fewer side effects than using isotretinoin alone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Acne is a common skin disease, affecting 
approximately 85% of adults. The increased secretion 
of sebum, the follicular hyperkeratosis, the presence 
of Propionibacterium acnes and inflammatory 
response are the four major factors in the acne 
pathogenesis [1]. Currently, isotretinoin is the only 
drug that targets all the causative factors of acne. This 
medicament is also effective in acne cases 
unsuccessfully treated with other therapeutic agents. 
However, isotretinoin results in some side effects 
including dry skin cracked lips, erythema and rashes. 
Antihistamines H1 have been used for a long 
time to treat pruritus and allergic conditions. Recently, 
they have also been used in acne treatment because 
of their ability to reduce sebum and side effects 
created by isotretinoin [2]. Some studies also mention 
the effect of antihistamines in reducing inflammation 
and preventing acne scars. 
In Vietnam, there has been no evaluation 
study done on the use of antihistamines in acne 
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treatment.  
This study aimed to evaluate the efficacy of 
oral isotretinoin used alone and in combination with 
desloratadine in the treatment of moderate acne 
vulgaris. 
 
 
Methods 
 
A comparative clinical trial on 62 moderate 
acne vulgaris patients was conducted at the National 
Hospital of Dermatology and Venereology, from 
August 2017 to August 2018. 
A group of 62 patients were randomised into 2 
equal groups: studied group and control group. 
Both groups were treated with isotretinoin 
20mg per day in 16 weeks. The combined treatment 
was 5mg desloratadine daily in 16 weeks for the 
studied group.  
For the evaluation, we counted the number of 
acne lesions, scoring GAGS (Global Acne Grading 
System), recording unwanted effects after 2, 4, 8, 12 
and 16 weeks of treatment.  
Evaluation of acne outbreak during treatment 
was based on the appearance of new nodules at each 
re-examination. We used a scale of no outbreak (no 
new lesion), mild outbreak (< 5 nodules), moderate 
outbreak (5-10 nodules) and severe outbreak (≥ 10 
nodules).  
The evaluation of clinical efficacy after 16 
weeks of treatment was scaled of:  
- Excellent: no inflammation and non-
inflammation lesions. 
- Good: reduced by ≥ 90% of the number of 
lesions. 
- Fair: reduced by ≥ 75-90% of the number of 
lesions. 
- Moderate: reduced by ≥ 50-75% of the 
number of lesions. 
- Poor: reduced by <50% of the number of 
lesions. 
 
 
Results 
 
General characteristics of the included 
objects  
At the initiation time of treatment, the two 
groups had similar characteristics regarding patient 
gender, age, average illness duration, number of 
lesions, illness severity and isotretinoin dose, as 
presented in Table 1. 
Table 1: Characteristics of patients in both groups before 
treatment 
Indicator 
Studied group  
(n = 31) 
Control group 
(n = 31) 
p 
Sex 
Male (n) 11 12 
p = 0,074 
Female (n) 20 19 
Mean age (years) 21,90 ± 4,1 22.06 ± 4.20 p = 0.88 
Mean duration of disease 
(months) 
38,74 ± 34,44 43.16 ± 26.62 p = 0.55 
Mean weight (kg) 52,32 ± 8,56 57.61 ± 9.90 p = 0.186 
The number of inflammatory 
lesion  
20,29 ± 1,94 19.58 ± 8.60 p = 0.172 
 The number of non-
inflammatory lesion 
48,90 ± 29,36 47.87 ± 25.44 p = 0.345 
Total no of lesions 68,87 ± 35,86 68.45 ± 28.95 P = 0.182 
Mean GAGS score  22,90 ± 3,11 22.77 ± 3.03 p = 0.869 
 
 
Treatment results 
Change in the number of inflammatory lesions 
In the studied group, the number of 
inflammatory lesions was significantly lower than that 
in the control group, with p < 0.025 as shown in Figure 
1. 
 
Figure 1: The numbers of inflammatory lesions 
 
Change in the illness severity score 
An illness severity score of the studied group 
was significantly lower than that in the control group 
from week 4 onwards with p < 0.05 as shown in Table 
2. 
Table 2: Change in the illness severity score 
Time Studied group Control group p 
Week 0 22.9 ± 3.11 22.77 ± 3.03 0.869 
Week 2 20.5 ± 4.22 21.45 ± 4.31 0.388 
Week 4 17.11 ± 4.22 19.35 ± 4.70 0.06 
Week 8 13.78 ± 5.48 15.03 ± 4.11 0.025 
Week 12 8.44 ± 5.40 12.03 ± 4.27 0.007 
Week 16 3.71 ± 3.81 6.52 ± 4.35 0.015 
 
 
Treatment efficacy after 16 weeks 
The studied group had 45.2% of acne 
resolved, higher than that in the control group: 22.6%, 
with p < 0.05 as shown in Figure 2. 
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Figure 2: Treatment efficacy after 16 weeks 
 
Unwanted effects 
Acne outbreak 
The studied group had a significantly lower 
outbreak rate than that in the control group with p < 
0.05 at week 2 and 4. At week 16, both groups had no 
outbreaks. 
 
Figure 3: 26 years old female from the studied group (Isotretinoin + 
Desloratadine) 
 
Other unwanted effects 
At the time of follow-up, both groups 
experienced side effects such as dried skin, dried lips, 
itching. In the studied group, the rate of itching was 
significantly lower than the control group (week 2: 
12.9%; week 4: 6.2% versus 64.5% in week 2 and 
71% in week 4). There was no difference between the 
two groups regarding side effects such as dried lips, 
dried skin, flaking and blushing. 
 
 
Discussion 
 
Studies have shown that inflammation in acne 
starts very early, even before the appearance of the 
lesion and continues at all stages of acne lesion 
development [3]. Acne inflammation response is due 
to the release of inflammatory mediators such as 
histamine and leukotrienes. Therefore, the use of 
antihistamines can effectively prevent the formation of 
new acne lesions and have a significant impact on 
resolving the old acne lesions. In our study, the 
average number of inflammatory lesions in the studied 
group was significantly lower than that in the group 
using only isotretinoin. The reason probably is the 
combination of anti-inflammatory effects of both 
retinoids and antihistamines. However, we did not find 
any difference in the reduction of non-inflammatory 
lesions between the two groups. 
 
Figure 4: 24 years-old female from the control group (Isotretinoin) 
 
After 16 weeks, the mean GAGS score in the 
studied group was lower than in the control group 
(3.71 ± 3.81 vs 6.52 ± 4.35), with p = 0.015. In Lee's 
study, the reduction of GAGS scores in the studied 
group was seen from week 2. However, the significant 
difference was just from week 4 onwards [2]. Yosef's 
study showed similar results [4]. 
After 16 weeks of treatment, both groups had 
good outputs: the studied group achieved 45.2% 
excellent, 35.5% good, and remaining 19.3% fair; the 
results in the control group were 22.6%, 29%, and 
49.1% average response, respectively. However, our 
results showed that the desloratadine group was 
better (p < 0.05). Experimental studies have shown 
that desloratadine inhibits inflammatory mediators 
including IL-4, IL-6, IL-8, IL-13, prostaglandins, 
leukotriene, tryptase and histamine [5]. Thus, 
desloratadine acts as an anti-inflammatory role. Also, 
desloratadine also reduces the formation of squalene, 
an important component of the sebum [6], [7]. In Lee's 
study, the studied group had 40% of cases clear, 50% 
improvement while the control group had 20% of 
patients clear, 40% improvement [2]. Studies by 
Dhaher SA and Jasim ZM showed the same results of 
50% excellent result, 39.5% good results in the 
studied group while control group were 31.6% 
excellent, 34.2% good, 26.3% average and 7.9% poor 
[8]. 
Acne outbreaks are common side effects after 
starting treatment with isotretinoin for 2-4 weeks. The 
mechanism of the outbreak is unclear, but it is related 
to the release of P. acnes and sebaceous gland 
antigens, enhancing the inflammatory response [9]. In 
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our study, the anti-inflammatory effect of 
antihistamines may have resulted in mild outbreak 
rate of the studied group: 22.6% at week 2, 16.1 % at 
week 4, that were lower than those in control group 
(45.2% and 38.7%, respectively). Similar results were 
seen in Lee's study [2]. 
In our study, the itching was less common in 
the studied group, attributed to the effects of 
desloratadine.  
In conclusion, treating moderate acne vulgaris 
with oral isotretinoin in combination with 
antihistamines enhances the curative effectiveness 
and reduces side effects of itching and acne 
outbreaks, that is linked with oral isotretinoin intake. 
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